- Home
- AUUD vs ALZN Comparison
AUUD vs ALZN Comparison
Compare AUUD & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- ALZN
- Stock Information
- Founded
- AUUD 2012
- ALZN 2016
- Country
- AUUD United States
- ALZN United States
- Employees
- AUUD N/A
- ALZN N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- AUUD Technology
- ALZN Health Care
- Exchange
- AUUD Nasdaq
- ALZN Nasdaq
- Market Cap
- AUUD 2.8M
- ALZN 2.3M
- IPO Year
- AUUD 2021
- ALZN 2021
- Fundamental
- Price
- AUUD $2.65
- ALZN $2.44
- Analyst Decision
- AUUD
- ALZN Strong Buy
- Analyst Count
- AUUD 0
- ALZN 1
- Target Price
- AUUD N/A
- ALZN $180.00
- AVG Volume (30 Days)
- AUUD 2.5M
- ALZN 194.5K
- Earning Date
- AUUD 08-19-2025
- ALZN 09-10-2025
- Dividend Yield
- AUUD N/A
- ALZN N/A
- EPS Growth
- AUUD N/A
- ALZN N/A
- EPS
- AUUD N/A
- ALZN N/A
- Revenue
- AUUD N/A
- ALZN N/A
- Revenue This Year
- AUUD N/A
- ALZN N/A
- Revenue Next Year
- AUUD N/A
- ALZN N/A
- P/E Ratio
- AUUD N/A
- ALZN N/A
- Revenue Growth
- AUUD N/A
- ALZN N/A
- 52 Week Low
- AUUD $2.37
- ALZN $2.06
- 52 Week High
- AUUD $31.62
- ALZN $135.54
- Technical
- Relative Strength Index (RSI)
- AUUD 34.45
- ALZN 39.06
- Support Level
- AUUD $2.37
- ALZN $2.20
- Resistance Level
- AUUD $3.78
- ALZN $2.44
- Average True Range (ATR)
- AUUD 0.60
- ALZN 0.17
- MACD
- AUUD -0.19
- ALZN -0.00
- Stochastic Oscillator
- AUUD 7.16
- ALZN 38.78
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.